Patients with mild dementia get more health insurance coverage

Published: 2010-04-07 06:57:00

Updated: 2010-04-07 06:57:00

The government has expanded its support for patients suffering from mild dementia of the Alzheimer type and receiving Reminyl (galantamine) from this month, the Ministry of Health and Welfare announced recently.

Reminyl is used to treat the symptoms of mild to moderately severe dementia of the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK